MedTrace Logo

Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis

NCT06109805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1706

Last updated 2025-02-20

No results posted yet for this study

Summary

The aim of this observational study is to comprehensively analyze the metabolites in plasma samples from gastric cancer patients using advanced mass spectrometry detection technology, in conjunction with both broad-spectrum and targeted metabolomics approaches. The goal is to construct a dedicated plasma metabolite database for gastric cancer patients. Simultaneously, we will delve into the exploration and validation of a series of metabolic biomarkers for early gastric cancer diagnosis. The objective is to establish a safer, more convenient, and more sensitive early screening method, thereby providing a reliable scientific foundation and critical evidence for improving the early diagnostic process for individuals at high risk of gastric cancer.

Conditions

Interventions

OTHER

Gastric cancer

Patients diagnosed with gastric cancer, including early gastric cancer and advanced gastric cancer

Sponsors & Collaborators

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Li Min, Ph.D. · Beijing Friendship Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-20
Primary Completion
2025-02-18
Completion
2025-02-18

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06109805 on ClinicalTrials.gov